IRIS
BURONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.488
AS - Asia 2.602
EU - Europa 2.112
SA - Sud America 406
AF - Africa 115
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 8.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.385
CN - Cina 1.193
SG - Singapore 560
IE - Irlanda 493
BR - Brasile 311
HK - Hong Kong 304
RU - Federazione Russa 269
DE - Germania 253
VN - Vietnam 237
UA - Ucraina 213
FI - Finlandia 199
IT - Italia 186
FR - Francia 137
GB - Regno Unito 127
SE - Svezia 105
IN - India 68
ZA - Sudafrica 57
CA - Canada 54
AR - Argentina 38
BD - Bangladesh 36
JP - Giappone 31
MX - Messico 30
IQ - Iraq 25
PL - Polonia 23
JO - Giordania 22
ES - Italia 19
CO - Colombia 16
ID - Indonesia 16
TR - Turchia 16
BE - Belgio 14
EC - Ecuador 13
AU - Australia 12
LT - Lituania 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
EG - Egitto 11
NL - Olanda 11
AT - Austria 10
PK - Pakistan 10
UZ - Uzbekistan 10
MA - Marocco 9
NG - Nigeria 9
CL - Cile 8
PH - Filippine 7
BO - Bolivia 6
GR - Grecia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KE - Kenya 5
KG - Kirghizistan 5
MU - Mauritius 5
MY - Malesia 5
NP - Nepal 5
TH - Thailandia 5
CH - Svizzera 4
HU - Ungheria 4
IL - Israele 4
PA - Panama 4
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
CG - Congo 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
IR - Iran 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
RO - Romania 2
ZM - Zambia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GH - Ghana 1
GM - Gambi 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MM - Myanmar 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
Totale 8.736
Salva come PNG Salva come JPEG
Città #
Chandler 489
Dublin 485
Ashburn 347
Singapore 321
Hong Kong 300
Beijing 292
San Jose 284
Jacksonville 256
Dallas 255
Nanjing 194
Boardman 136
Los Angeles 97
Ho Chi Minh City 91
Helsinki 86
Lauterbourg 85
Princeton 80
Lawrence 75
Nanchang 68
Pavia 67
Wilmington 67
Medford 64
Ann Arbor 63
Jiaxing 63
Munich 61
New York 59
Shenyang 59
Hanoi 58
Shanghai 56
Changsha 55
Hebei 53
Johannesburg 51
Moscow 46
Hangzhou 42
Buffalo 38
Tianjin 33
Redondo Beach 28
Tokyo 28
Santa Clara 27
São Paulo 27
Frankfurt am Main 26
Milan 25
The Dalles 22
Woodbridge 22
Amman 21
Denver 21
Orem 21
Brooklyn 19
San Francisco 19
Council Bluffs 18
London 18
Turku 18
Warsaw 18
Toronto 16
Houston 15
Montreal 15
Norwalk 15
Stockholm 15
Columbus 14
Da Nang 14
Boston 13
Brussels 13
Chicago 13
Mexico City 13
Phoenix 13
Poplar 13
Mumbai 12
Seattle 12
Verona 12
Washington 12
Baku 11
Brasília 11
Falkenstein 11
Ottawa 11
Rio de Janeiro 11
Atlanta 10
Baghdad 10
Falls Church 10
Nuremberg 10
Olomouc 10
Tashkent 10
Fairfield 9
Haiphong 9
Hyderabad 9
Hải Dương 9
Lagos 9
Manchester 9
Porto Alegre 9
Rome 9
Chennai 8
Piscataway 8
Redwood City 8
Vienna 8
Des Moines 7
St Petersburg 7
Belo Horizonte 6
Can Tho 6
Curitiba 6
Florence 6
Guangzhou 6
Jakarta 6
Totale 5.753
Salva come PNG Salva come JPEG
Nome #
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 171
Antistaphylococcal activity of the ftsz inhibitor c109 160
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 159
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 156
Analyzing the role of RND efflux transporters in Burkholderia cenocepacia: a proteomic analysis. 149
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 149
A census of RND superfamily proteins in the Burkholderia genus. 145
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 141
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 141
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii 140
Differential role of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells 140
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 139
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study 139
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 133
Bombas de eflujo como trasportadores de membrana implicados en resistencia a antibióticos en micobacterias 130
Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections 130
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 129
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 128
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 128
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 127
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 126
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 125
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. 124
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 121
Molecular characterization of the burkholderia cenocepacia dcw operon and ftsz interactors as new targets for novel antimicrobial design 121
Study of the regulation of lfrA gene coding for an antibiotic efflux pump of Mycobacterium smegmatis. 120
Contribution of the Mycobacterium tuberculosis efflux pumps to drug resistance 119
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 119
Espressione, purificazione ed analisi funzionale della NAD+ sintetasi di Mycobacterium tuberculosis, un enzima essenziale 118
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 117
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. 116
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 116
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 115
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 111
A new promising bactericidal compound against Burkholderia cenocepacia. 111
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 111
Studies on the identification and characterization of the cellular target of the potential antitubercular drug BM212. 110
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 109
Mycobacterium tuberculosis: drug resistance and future perspectives 109
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 108
CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus 107
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 106
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. 105
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 103
Methodological tools to study species of the genus Burkholderia 103
AI is a viable alternative to high throughput screening: a 318-target study 101
Identification of the cellular target of the potential antitubercular drug BM 212 100
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 99
Role of rnd efflux pumps in drug resistance of cystic fibrosis pathogens 99
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa 98
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems. 96
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 96
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. 92
Antivirulence compounds: a future direction to overcome antibiotic resistance? 90
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 88
The crystal structure of Burkholderia cenocepacia DfsA provides insights into substrate recognition and quorum sensing fatty acid biosynthesis 88
Fighting against resistant strains: the case of benzothiazinones and dinitrobenzamides 88
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses 86
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens 85
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia. 84
Molecular basis for antibiotic resistance in the genus Burkholderia 84
The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It 81
The role of RND efflux transporters in intrinsic antibiotic resistance of Burkholderia cenocepacia 81
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 81
Antibiotics sustainability: another issue in the fight against antimicrobial resistance. 81
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 80
Quorum sensing as antivirulence target in cystic fibrosis pathogens 80
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa MDR clinical isolates. 77
Recent advances to combat ESKAPE pathogens with special reference to essential oils 73
New antivirulence compounds affecting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 72
Illumina-based chemogenomic profiling of a novel compound with antimicrobial activity reveals its role as a cell division inhibitor. 72
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 69
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. 67
Mycobacterium tuberculosis efflux pumps: an update 67
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis 66
THERAPEUTIC STRATEGIES TO COMBAT STAPHYLOCOCCUS AUREUS INFECTIONS IN CYSTIC FIBROSIS 64
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 64
The role of RND efflux transporters in Burkholderia cenocepacia life. 62
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 62
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 60
Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms 57
Phenylacetyl-CoA, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 57
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 50
Editorial: Community series in insights into new strategies to combat biofilms, volume II 44
Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed 44
Editorial: Insights Into New Strategies to Combat Biofilms 40
Editorial: Burkholderia spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment 34
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 31
Synthesis, structural characterization, and biological evaluation of cinnamaldehyde–azomethine hybrids: In Vitro and In Silico approaches 25
Liposomal tobramycin and ceftazidime as advanced nanocarriers against Pseudomonas aeruginosa infections 23
Totale 8.922
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 60 56 13
2021/2022362 7 5 1 17 11 12 9 20 18 11 57 194
2022/20231.329 127 113 12 125 126 119 12 83 557 7 29 19
2023/2024569 62 89 19 30 40 119 26 60 5 40 46 33
2024/20251.533 23 101 44 32 64 87 116 94 384 65 196 327
2025/20263.249 301 201 406 389 498 153 617 155 334 195 0 0
Totale 8.922